ELISA SETD2 anti-

Quantity :50µL Clone Number: Aliases:EC 2.1.1.43 antibody; FLJ16420 antibody; FLJ22472 antibody; FLJ23184 antibody; FLJ45883 antibody; HBP231 antibody; HIF 1 antibody; HIF-1 antibody; HIF1 antibody; HIP-1 antibody; Histone lysine N methyltransferase SETD2 antibody; Histone-lysine N-methyltransferase SETD2 antibody; hSET2 antibody; HSPC069 antibody; Huntingtin interacting protein 1 antibody; Huntingtin interacting protein antibody; Huntingtin interacting protein B antibody; Huntingtin interacting protein HYPB antibody; Huntingtin yeast partner B antibody; Huntingtin-binding protein; 231-KD antibody; Huntingtin-interacting protein 1 antibody; Huntingtin-interacting protein B antibody; HYPB antibody; KIAA1732 antibody; KMT3A antibody; Lysine N methyltransferase 3A antibody; Lysine N-methyltransferase 3A antibody; p231HBP antibody; SET domain containing 2 antibody; SET domain-containing protein 2 antibody; SET2 antibody; SETD2 antibody; SETD2_ antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:Q9BYW2 Immunogen:Fusion protein of SETD2 Raised in:Rabbit Reactivity:, Mouse Tested Applications:ELISA, IHC; ELISA:1:1000-1:5000, IHC:1:50-1:200 Background:Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. Clonality:Polyclonal Isotype:IgG Purification Method:Antigen affinity purification Conjµgate:Non-conjµgated Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:SETD2 Research Areas:Epigenetics and Nuclear Signaling